GSK enquiries
| |||
Media:
|
Tim Foley
|
+44 (0) 20 8047 5502
|
(London)
|
Simon Moore
|
+44 (0) 20 8047 5502
|
(London)
| |
Kathleen Quinn
|
+1 202 603 5003
|
(Washington DC)
| |
Lyndsay Meyer
|
+1 202 302 4595
|
(Washington DC)
| |
Investor Relations:
|
Nick Stone
|
+44 (0) 7717 618834
|
(London)
|
James Dodwell
|
+44 (0) 20 8047 2406
|
(London)
| |
Mick Readey
|
+44 (0) 7990 339653
|
(London)
| |
Josh Williams
|
+44 (0) 7385 415719
|
(London)
| |
Jeff McLaughlin
|
+1 215 751 7002
|
(Philadelphia)
| |
Frannie DeFranco
|
+1 215 751 4855
|
(Philadelphia)
| |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
GSK plc published this content on 21 October 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 21 October 2022 16:39:04 UTC.